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Exercise intervention studies in men with prostate cancer have
shown well documented improvements in objective and self-
reported outcomes [1] with higher levels of physical activity also
associated with reduced prostate cancer specific and overall
mortality [2]. Recently, exercise has been proposed as a medicine
in the setting of oncology with initial recommendations presented
to guide clinicians in directing and referring patients to undertake
exercise programs during/following treatments [3].
However, despite supporting data from several clinical trials, the
majority of men with prostate cancer do not undertake exercise
programs or are regularly physically active. For example, we
previously reported data of a population-based cohort of
metropolitan and rural Australian men with prostate cancer on
adherence to exercise-oncology recommendations including aero-
bic and resistance exercise modes [4]. Only ~12% of men reported
undertaking recommended exercise levels (150min of moderate
intensity or 75min of strenuous exercise per week and twice
weekly resistance exercise) with ~47% being completely inactive
[4]. As expected, lack of physical activity also contributed to poorer
quality of life. Given the low use of exercise in the clinical setting
when treating men with prostate cancer and overall low levels of
physical activity of these men, identifying barriers, facilitators and
preferences to increase exercise participation and referrals to
exercise programs that can improve outcomes in men with
prostate cancer should be an important priority.
In this issue of Prostate Cancer and Prostatic Diseases, Sattar
et al. [5]. presented findings from a comprehensive scoping
review examining facilitators, preferences, and barriers to exercise
and physical activity in men with prostate cancer. The authors
reported 46 studies presenting quantitative and qualitative
results on these outcomes and are to be commended for this
work. For the purpose of their review, physical activity was defined
as any bodily movement produced by skeletal muscles that
results in energy expenditure, with the inclusion of structured
planned exercise as well as sport-based activities with the
intention to capture all studies. From a treatment perspective,
studies involved men with prostate cancer who had received a
prostatectomy or were undergoing and/or had received andro-
gen deprivation therapy (ADT) with or without radiation therapy.
The authors report that the main preference among men with
prostate cancer was to exercise in a structured group environment.
Our clinical and research experience is that group exercise is highly
engaging for men with prostate cancer and facilitates the uptake of
exercise programs and enhances long-term adherence to exercise.
Structured group exercise likely facilitates the interaction with peers
and provides as a supportive group environment. However, in
studies including patients with other cancers, exercise preferences
have differed across reports in terms of patient preferences in
relation to undertaking exercise in a group format vs. alone or other
components of exercise programming including different modes of
exercise, location of the exercise program and supervision. For
example, in a early study in this field which included patients with
prostate, breast, colorectal and lung cancer, patients reported a
preference to exercise alone [6]. Clearly, an approach that considers
individual preferences must be used when planning the prescription
of exercise programs to ensure long-term adherence and compli-
ance. However, in addition to patient preferences, it is important to
inform patients that specific exercise programs may be required to
achieve defined exercise goals (e.g., reduce body fat, counteract loss
of muscle mass following/during ADT). Consequently, a balance
between patient preference and specificity of exercise to improve
patient outcomes should be recommended.
A common barrier to participation in exercise programs
reported among cancer patients was treatment-related side-
effects. Again, it is important for patients to be well-informed on
the benefits of exercise in reducing specific treatment-related
adverse effects. For example, in the case of fatigue during ADT,
men with prostate cancer with the highest levels of fatigue and
lowest vitality have reported the greatest benefits in a previous
yearlong study suggesting an important exercise response in
those with more symptoms at baseline [7]. Another exercise
barrier reported consistently across many studies is lack of time. If
exercise is to be viewed as part of the treatment plan with clear
referral pathways to an exercise specialists then this may facilitate
exercise adoption and participation. For example, in a large study
of 859 men with prostate cancer where exercise was offered as
part of the treatment plan in patients receiving leuprorelin
acetate, a very high compliance rate of 92% was reported [8]. In
our view, having exercise as part of the treatment plan is a major
facilitator to improve participation.
The authors also reported on masculinity as a prominent theme
noted from patient perspectives. In our experience, a key care
consideration in men with prostate cancer is the adoption of a
men-centered approach that considers masculinities and gender-
specific care preferences. Physical strength, fitness, and an action-
oriented coping approach are described by men as aspects of
masculinity important in their prostate cancer experience [9]. In
this sense, if appropriately framed and presented to men, exercise
medicine has a unique capacity to overcome barriers to help-
seeking by simply being more socially or personally acceptable. In
brief, exercise medicine provides the opportunity to work
synergistically with masculine values to assist in recovery from a
psychological and masculine identity perspective, thereby improv-
ing patient outcomes.
Last, exercise medicine has the potential to support or enhance
personal agency (defined as the capacity of an individual to
initiate, execute and manage their actions in response to the
awareness and ownership of health‐related needs), an essential
core component of quality survivorship care [10]. It is notable that
in a recent review of survivorship interventions strong evidence
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was found for the effectiveness of both exercise medicine and
psychosocial interventions to improve patient outcomes [11].
Survivorship care that incorporates these domains of care is
essential.
In all, it is now time to break exercise barriers and promote
exercise facilitators so we can have more men with prostate cancer
walking, running, cycling, lifting weights, and benefiting from
exercise medicine!
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